World-first therapy to target endometriosis and deadly cancer Herald Sun
World-first therapy to target endometriosis and deadly cancer The Mercury
World-first therapy to target endometriosis and deadly cancer Gold Coast Bulletin
Adenomyosis often coexists with endometriosis, which primarily involves the ovary and can lead to endometriosis‑associated ovarian cancers, most commonly endometrioid and clear‑cell carcinomas. Ovarian squamous cell carcinoma (OSCC) arising in …
Limited research has examined psychological treatments for endometriosis-related chronic pain, despite its association with elevated disability, depression, and anxiety. Remotely delivered treatments have the potential to overcome barriers to access …
Subclinical leaflet thrombosis (SLT) following transcatheter aortic valve replacement occurs in 10% to 15% of patients at 1 month and up to 30% by 1 year, extending to perivalvular structures …
Menstrual blood (MB), a biofluid rich in diverse cell types and biomolecules, has emerged as a vital resource for investigating female reproductive health and diseases because of its unique composition …
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer Nature
Endometriosis contributes to 5-21% of hospital admissions for pelvic pain. While hormonal therapies are pivotal in managing endometriosis-related pain, no single hormonal treatment suits all patients. We aimed to assess …
Cesarean scar endometriosis is a rare form of endometriosis characterized by the presence of functional endometrial tissue within a surgical scar. Diagnosing this condition is challenging, as it is frequently …